Great news for our patients with bladder cancer!! Phase 3 KEYNOTE-A39/EV-302 Trial Met Dual Primary Endpoints of OS and PFS in Certain Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer. ⁦UW Health | Carbone Cancer Center⁩ merck.com/news/merck-ann…

Concurrent durvalumab and radiation therapy #DUART followed by adjuvant durvalumab in pts with localized #UrothelialCancer of the #bladder : results from a P II study, BTCRC-GU15-023 #BeyondTheAbstract > bit.ly/3KJXong Hamid Emamekhoo UW Health | Carbone Cancer Center MJ Journal for ImmunoTherapy of Cancer

Considering #ePROs implementation for patients with #cancer at your institution? Checkout our new ⁦National Comprehensive Cancer Network (NCCN)⁩ ePRO WG paper published in ⁦ACS Journal Cancer. ⁦UW Health | Carbone Cancer Center⁩ ⁦UW Applied Clinical Informatics⁩ ⁦ASCO⁩ ⁦AMIA⁩ acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

Congratulations to Dr. David Schneider Dave Schneider, Associate Program Director of our fellowship and Medical Informatics Director of Virtual Care UW Health on induction into the #FAMIA Class of 2023!

UW-Madison Department of Surgery UW School of Medicine and Public Health AMIA

The two keys for unlocking the productivity paradox! Nicely portrayed in the keynote presentation AMIA #CIC23 by Dr Robert Wachter. UW Applied Clinical Informatics

Under the Bean in #Chicago with the ⁦UW Applied Clinical Informatics⁩ team attending #AMIA #CIC23 meeting.

I’m proud of our #UWinformatics team & our #clinicaltrial staff & investigators UW Health | Carbone Cancer Center for their dedication to outstanding care & their willingness to adopt a new platform! Their feedback made this EHR integrated AE reporting system a better tool. #XGM2023

UW Applied Clinical Informatics Hamid Emamekhoo AnnWieben UW Health UW School of Medicine and Public Health UW Hematology-Oncology and Palliative Care Joel Gordon #2 in the world at effectively tracking signs, symptoms, or abnormal labs while on a study. This helps clinicians determine the true risk/benefit analysis of a new treatment.

From patient portal use patterns to NLP, our #ClinicalInformatics team was busy at the Department of Medicine Research Day!
Peter Kleinschmidt Hamid Emamekhoo UW-Madison Critical Care Medicine Data Science Lab University of Wisconsin Department of Medicine

ESMO22 renal cancer highlights: 1st line trials: Cabo/ipi/nivo vs ipi/nivo (+veDFS).Bempegaldesleukin (peg il-2)+nivo vs VEGF TKI (-ve RR/OS). 2 negative adjuvant trials with atezo and ipi/nivo not showing a DFS advantage (in contrast to pembro). Finally a neoadjuvant nivo RIII.

UMANA IL receives '2022 Humanitarian Global Health Award'. Thank you all for the efforts to support Ukraine! UW Health | Carbone Cancer Center UW Hematology-Oncology and Palliative Care ECOG-ACRIN Cancer Research Group Ulyana Khaba Douglas Davis
umana.org/umana-illinois…

#ASCO22 Important data presented by Robert Motzer MD of HRQoL and its association with clinical outcomes in patients with advanced #kidneycancer from the Checkmate-214 trial
ASCO OncoAlert

This is gonna be fun, so much has changed in advanced prostate cancer in just the last year alone! And I get to hang out with pretty fantastic clinician scientists 😊

#NCCN2022 Virtual Care is here to stay! 22 States with parity laws. #CancerTreatment ASCO National Comprehensive Cancer Network (NCCN) UW Health | Carbone Cancer Center

#NCCN2022 summary of recommendations on #Telemedicine in #Oncology presented by Dr. Robin Zon. National Comprehensive Cancer Network (NCCN) Annual Conference. Travis Osterman, DO, MS, FAMIA, FASCO @AmyeTevaarwerk1 UW Health | Carbone Cancer Center

Great news for our Pts with Metastatic CRPC #ProstateCancer ! FDA Oncology approved Lutetium-177-PSMA-617 PLUVICTO after prior ARAT/NHT and chemo. Our team ⁦UW Health | Carbone Cancer Center⁩ is getting ready to provide this treatment ⁦UW Health⁩ ⁦UW School of Medicine and Public Health⁩ onclive.com/view/fda-appro…

Learning to do this was life changing for me. It's a multi step process..

We are looking for a talented laboratory scientist to help lead our translational #BladderCancer & Rare #GU Tumors program Team at the Genitourinary Malignancies Branch at the NCI in Bethesda NCI Center for Cancer Research NCI CCR GU Malignancies
If interested please DM me ccr.cancer.gov/careers/staff-…